According to the National Hemotherapy Production Information System (Hemoprod), in
In 2012, Brazil produced about 4.2 million blood components
of donors, and performed approximately 3.5 million transfusion procedures. There was
increased concern about ensuring transfusion safety, motivated by
mainly due to the AIDS epidemic. The national average of clinical unfitness of candidates for
blood donation according to the Hemoprod bulletin in 2013 was approximately
18.5%. The average value attributed to the national serological inability was 3.43% and among the
markers of blood-borne diseases most related to serological inadequacy,
were Anti-HBc, followed by Syphilis and HIV. However, data related to the clinical profile and
serological status of candidates considered unfit for blood donation are still little
explored in Brazilian studies, despite their special importance. The present study had
in order to analyze the clinical and serological profile of the donation candidates considered unfit
at the Blood Center of the State of Amapá from 2014 to 2016. This is a descriptive study,
transversal, quantitative in nature. Data fed into the operating system was used
Hemovida from the Blood Center of the State of Amapá, which were analyzed descriptively and
presented in graphs and tables. The unfit candidate in the most frequent clinical screening in this
study was female, aged between 29 and 65 years, performing replacement donation;
the main cause of disability in clinical screening being low hematocrit, which may be
related to the high frequency of unfit female donors, in which the hyperflow
menstruation is the main cause of anemia in this group. While for the unfit in the
serological screening was predominantly the male donor, aged between 29 and 65 years,
unfit due to positive serology for hepatitis B, demonstrating the importance of
public policies to control HBV infection in the region. Note the importance of
careful clinical screening, considering that it excluded 30.72% of the candidates for donation in the
period, thus avoiding unnecessary spending on donors with a high probability of having their
bag excluded in the serological screening process, and also the relevance of serological screening
be done properly, thus promoting the safety of the transfusion process.
|
